Tonix Pharmaceuticals Holding Corp. logo
Tonix Pharmaceuticals Holding Corp. TNXP
$ 0.14 -2.07%

Квартальный отчет 2024-Q3
добавлен 12.11.2024

report update icon

Tonix Pharmaceuticals Holding Corp. Мультипликаторы 2011-2024 | TNXP

Мультипликаторы по годам Tonix Pharmaceuticals Holding Corp.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.0 -0.0 -0.9 -2.5 -0.1 -0.1 -1.3 -0.4 -1.7 -2.3 -4.4 - -

P/S

0.4 - - - - - - - - - - - -

EPS

-6.8 -20.0 -8.1 -0.6 -19.3 -259.9 -31.7 -15.4 -28.6 -2.8 -3.4 -5.6 -3.2

EV (Enterprise Value)

27.2 млн -97.7 млн -69 млн 58.1 млн -3.98 млн -20.2 млн 3.44 млн -2.42 млн 68.8 млн 27.6 млн 41.6 млн -627 тыс. 2.84 млн

EBITDA per Share

-6.7 -19 -8.1 -0.397 -17.9 -240 -318 -1.54 тыс. -2.86 тыс. -2.77 тыс. -3.36 тыс. - -

EV/EBITDA

-25.6 -0.9 0.3 0.9 -0.1 0.1 -1.3 -0.9 -3.6 0.2 -

PEG

-0.0 -0.0 -0.0 0.04 -0.0 -0.01 -0.02 -0.01 0.52 -0.13 -0.11 - -

P/B

0.0 0.0 0.4 1.4 0.2 0.1 1.1 0.6 2.0 1.7 7.3 - -

P/CF

-0.0 -0.0 -1.2 -2.2 -0.1 -0.1 -1.4 -0.4 -1.9 -2.7 -5.6 - -

ROE %

-110.55 -53.20 -42.19 -57.57 -303.90 -110.25 -85.81 -153.16 -119.35 -76.52 -167.14 -984.38 -

ROA %

-75.53 -48.84 -38.31 -51.40 -196.58 -99.13 -78.95 -141.19 -102.20 -69.84 -124.59 -445.75 -

ROCE %

-112.18 -54.10 -42.21 -57.16 -305.93 -111.23 -86.45 -153.46 -119.31 -76.48 -166.87 -964.29 -

Current Ratio

3.2 12.2 10.9 9.0 2.7 9.8 12.4 12.8 7.0 11.5 3.9 1.8 -

DSO

- - - - - - - - - - - - -

DIO

525.0 - - - - - - - - - - - -

DPO

456.2 - - - - - - - - - - - -

Операционный цикл

525.0 - - - - - - - - - - - -

Финансовый цикл

68.9 - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Tonix Pharmaceuticals Holding Corp.

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.23 -19.28 -0.18 - -38.63 -49.23 -3.21 - -4.24 -7.64 -1.61 - -1.6 -2.25 -0.07 - -0.09 -0.23 -0.37 - -5.69 -9.42 -12.76 - -54.99 -7.23 -8.8 - -0.77 -0.65 -1.27 - -2.9 -4.97 -7.41 -0.71 -0.72 -0.73 -0.71 -0.83 -0.71 -0.61 -0.59 - -0.87 -0.95 -0.93 - -0.05 -1.01 -1.27 - -0.05 -0.02 -0.03

EBITDA per Share

-0.24 -18.7 -0.25 - -37.5 -48.8 -3.21 - -4.29 -6.48 -1.6 - -1.6 -2.25 -0.07 - -0.09 -0.23 -0.3 - -5.71 -9.5 -12.9 - -55.2 -7.26 -8.85 - -0.77 -0.65 -1.27 - -2.9 -4.97 -7.4 -7.12 -0.72 -0.73 -0.71 -0.83 -0.71 -0.61 -0.59 - -0.87 -0.95 -0.92 - -0.05 -1.01 -0.73 - -0.05 -0.02 -0.02

ROE %

-243.22 -247.22 -80.31 -63.29 -75.95 -65.46 -55.41 -35.50 -44.66 -41.16 -44.08 -33.89 -47.57 -52.08 -55.21 -38.15 -121.39 -190.94 -236.78 -211.44 -234.59 -174.51 -138.22 -78.18 -101.69 -102.04 -95.73 -63.50 -93.38 -99.75 -119.00 -123.65 -156.84 -159.87 -150.42 -119.35 -111.08 -98.72 -86.25 -76.52 -99.06 -125.96 -141.24 -110.21 -290.87 -424.09 -572.72 -571.50 -530.16 -308.16 -113.00 76.77 41.34 14.50 20.93

ROA %

-158.13 -163.25 -68.96 -56.27 -68.21 -60.07 -50.70 -32.13 -40.76 -37.44 -41.51 -32.33 -44.54 -48.13 -50.12 -34.06 -87.90 -129.53 -155.20 -136.77 -157.59 -124.57 -107.58 -70.30 -91.92 -92.73 -87.47 -58.42 -85.97 -91.89 -109.67 -113.99 -142.41 -143.04 -132.42 -102.20 -96.52 -87.10 -77.37 -69.84 -82.48 -99.09 -107.68 -82.15 -163.96 -210.40 -268.33 -258.79 -497.24 -653.88 -655.71 -442.82 -238.45 -83.63 -120.73

ROCE %

-247.63 -249.97 -86.98 -64.44 -77.36 -66.99 -56.57 -35.86 -45.03 -41.27 -44.10 -33.94 -47.63 -52.16 -55.29 -38.21 -122.00 -192.11 -238.63 -213.38 -236.80 -176.42 -139.66 -78.90 -102.61 -102.90 -96.53 -63.97 -93.98 -100.28 -119.47 -124.04 -157.33 -160.31 -150.80 -119.62 -111.28 -98.90 -86.39 -76.63 -99.16 -126.04 -141.32 -110.24 -291.15 -424.57 -573.44 -482.84 -441.50 -219.26 -23.85 76.78 41.34 14.50 20.93

Current Ratio

4.6 2.5 5.0 3.2 7.5 8.3 13.1 12.2 17.7 16.9 14.2 10.9 17.1 21.8 27.8 9.3 9.3 9.3 9.3 2.8 2.8 2.8 2.8 9.9 9.9 9.9 9.9 12.5 12.5 12.5 12.5 12.8 12.8 12.8 12.8 7.0 7.0 7.0 7.0 11.5 11.5 11.5 11.5 3.9 3.9 3.9 3.9 1.8 1.8 1.8 1.8 0.1 0.1 0.1 0.1

DSO

118.9 - - - 17.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

510.2 295.5 714.3 - 519.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

420.8 231.1 286.7 - 297.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

629.0 295.5 714.3 - 537.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

208.3 64.4 427.6 - 239.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD